StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer International Markets Generating >$500M Annual Revenue by Year

International Markets Generating >$500M Annual Revenue — Country count

Pfizer International Markets Generating >$500M Annual Revenue: 12 in FY2025, up 9.1% from a year earlier.

Latest, FY2025
12
Period ended Dec 31, 2025
Change on a year earlier
+9.1%
11 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K Note 17 — Significant Customers & Geographic Concentration.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInternational Markets Generating >$500M Annual Revenue — Country countYear on yearSource
FY2025Dec 31, 202512+9.1%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202411-21.4%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 202314-41.7%Form 10-K (filed 2026-02-26) ↗
FY2022Dec 31, 202224+14.3%Form 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 202121+162.5%Form 10-K (filed 2024-02-22) ↗
FY2020Dec 31, 20208-20.0%Form 10-K (filed 2023-02-23) ↗
FY2019Dec 31, 2019100.0%Form 10-K (filed 2022-02-24) ↗
FY2018Dec 31, 201810-9.1%Form 10-K (filed 2021-02-25) ↗
FY2017Dec 31, 2017110.0%Form 10-K (filed 2020-02-27) ↗
FY2016Dec 31, 201611-8.3%Form 10-K (filed 2017-02-23) ↗
FY2015Dec 31, 201512–Form 10-K (filed 2018-02-22) ↗

Cite this data

StockData. (2026). Pfizer International Markets Generating >$500M Annual Revenue, annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/conc-ex-us-countries

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.